Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Interest-Expense" stands at 0.043 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Chugai Pharmaceutical Co. Ltd.'s second quarter result of 0.0063 Billion JPY for the item "Interest Expense" represents a decrease of -8.75 percent compared to it's first quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 0.0063 Billion JPY for the item "Interest Expense" represents a decrease of -4.27 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 0.043 Billion JPY for the item "Interest Expense" represents a decrease of -0.65 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 49.51 percent compared to the value the year prior.
The 1 year change in percent is 49.51.
The 3 year change in percent is -18.89.
The 5 year change in percent is -95.82.
The 10 year change in percent is -4.47.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Expense | 905,699,262,464.00 |
![]() | Johnson & Johnson - Interest Expense | 486,508,953,600.00 |
![]() | AbbVie Inc - Interest Expense | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Expense | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Expense | 280,205,508,085.11 |